Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;289(1):223-5.
doi: 10.1007/s00404-013-2940-7. Epub 2013 Jul 12.

Persistent ascites resolving with gonadotropin-releasing-hormone-agonist 18 months after hospitalization for severe ovarian hyperstimulation syndrome

Cihan Comba  1 , Funda Gungor Ugurlucan, Ercan Bastu, Ahmet Cem Iyibozkurt, Samet Topuz
Affiliations

Persistent ascites resolving with gonadotropin-releasing-hormone-agonist 18 months after hospitalization for severe ovarian hyperstimulation syndrome

Cihan Comba et al. Arch Gynecol Obstet. 2014 Jan.

Abstract

Ovarian hyperstimulation syndrome (OHSS) is a life- threatening complication of controlled ovarian stimulation. One of the main symptoms of OHSS is ascites. Treatment is symptomatic with resolution of the symptoms over days to weeks. We report a case of severe OHSS with persistent ascites 18 months after the diagnosis. Persistent ascites secondary to OHSS was diagnosed and single dose leuprolide acetate depot 11.25 mg was administered. At follow-up, no ascites was observed.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Ugurlucan FG, Iyibozkurt AC, Baysal B. Ovarian hyperstimulation syndrome in a patient with frozen-thawed embryo transfer and dichorionic diamniotic pregnancy. Arch Gynecol Obstet. 2012;285:1759–1761. doi: 10.1007/s00404-011-2167-4. - DOI - PubMed
    1. Gómez R, Soares SR, Busso C, Garcia-Velasco JA, Simón C, Pellicer A. Physiology and pathology of ovarian hyperstimulation syndrome. Semin Reprod Med. 2010;28(6):448–457. doi: 10.1055/s-0030-1265670. - DOI - PubMed
    1. Kumar P, Sait SF, Sharma A, Kumar M. Ovarian hyperstimulation syndrome. J Hum Reprod Sci. 2011;4(2):70–75. doi: 10.4103/0974-1208.86080. - DOI - PMC - PubMed
    1. Abramov Y, Schenker JG, Lewin A, Friedler S, Nisman B, Barak V. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum Reprod. 1996;11:1381–1386. doi: 10.1093/oxfordjournals.humrep.a019404. - DOI - PubMed
    1. Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril. 2004;81:1–5. doi: 10.1016/j.fertnstert.2003.05.032. - DOI - PubMed

LinkOut - more resources